🆕
www.ceotodaymagazine.com
29/08/2026
Why Merck & Co. Is Rebuilding Clinical Research Around AI
The pharmaceutical industry has spent decades optimizing for caution. Clinical research is heavily regulated, operationally complex, and built around systems designed to minimize risk rather than accelerate change. That is why Merck & Co.’s approach